Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 107.03
-6.81 (-5.98%)
May 12, 2026, 3:00 PM CST
Beijing Hotgen Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -289.29 | -258.63 | -191 | 28.92 | 944.74 | 2,186 |
Depreciation & Amortization | 81.58 | 81.58 | 89.05 | 70.53 | 120.29 | 68.34 |
Other Amortization | 7.32 | 7.32 | 15.77 | 7.76 | 28.15 | 5.38 |
Loss (Gain) From Sale of Assets | -0.58 | -0.58 | 1.63 | 0.64 | 0.34 | 14.21 |
Asset Writedown & Restructuring Costs | 81.19 | 81.19 | 55.15 | 36.95 | 70.06 | 8.51 |
Loss (Gain) From Sale of Investments | -60.67 | -60.67 | 9.36 | 23.68 | -10.91 | -24.88 |
Provision & Write-off of Bad Debts | - | - | 1.36 | -13.4 | 11.34 | 0.7 |
Other Operating Activities | -5.32 | 14.6 | 24.39 | -59.57 | 94.17 | 118.58 |
Change in Accounts Receivable | 51.24 | 51.24 | -77.16 | 93.75 | -22.28 | -81.52 |
Change in Inventory | 13.39 | 13.39 | 47.59 | 123.21 | 36.03 | -213.43 |
Change in Accounts Payable | -3.73 | -3.73 | 3.31 | -284.98 | -242.99 | 564.77 |
Change in Other Net Operating Assets | -0.3 | -0.3 | -24.34 | -71.27 | -32.27 | 8.46 |
Operating Cash Flow | -133.94 | -83.36 | -37.16 | -48.53 | 978.75 | 2,644 |
Operating Cash Flow Growth | - | - | - | - | -62.99% | 1506.38% |
Capital Expenditures | -55.92 | -43.57 | -51.41 | -413.37 | -565.21 | -398.86 |
Sale of Property, Plant & Equipment | 1.7 | 1.7 | 1.19 | 3.74 | 0.58 | 0.13 |
Divestitures | - | - | -7.89 | -17.11 | -0.08 | - |
Investment in Securities | 78.16 | 256.62 | 130.21 | 238.61 | -602.42 | -1,367 |
Other Investing Activities | -3.24 | 34.17 | 38.74 | 26.56 | 17.08 | 22.34 |
Investing Cash Flow | 20.7 | 248.92 | 110.83 | -161.57 | -1,130 | -1,763 |
Long-Term Debt Issued | - | 321.18 | - | - | - | - |
Total Debt Issued | 271.18 | 321.18 | - | - | - | - |
Long-Term Debt Repaid | - | -46.82 | -5.12 | -27.24 | -32.29 | -11.4 |
Total Debt Repaid | -96.82 | -46.82 | -5.12 | -27.24 | -32.29 | -11.4 |
Net Debt Issued (Repaid) | 174.36 | 274.36 | -5.12 | -27.24 | -32.29 | -11.4 |
Issuance of Common Stock | 11.75 | 3.52 | 45.02 | 3.34 | - | - |
Repurchase of Common Stock | - | - | -92.03 | -16.44 | -150.04 | - |
Common Dividends Paid | -1.56 | -1.74 | -17.34 | - | -310.98 | -93.29 |
Other Financing Activities | -118.65 | -188.36 | -10 | 3.8 | 8.32 | 9.63 |
Financing Cash Flow | 65.9 | 87.78 | -79.48 | -36.55 | -484.99 | -95.07 |
Foreign Exchange Rate Adjustments | -3.08 | 1.46 | -0.15 | -0.46 | 5.2 | -14.83 |
Net Cash Flow | -50.42 | 254.79 | -5.96 | -247.11 | -631.09 | 771.69 |
Free Cash Flow | -189.86 | -126.93 | -88.57 | -461.9 | 413.54 | 2,246 |
Free Cash Flow Growth | - | - | - | - | -81.58% | - |
Free Cash Flow Margin | -44.40% | -31.35% | -17.34% | -84.31% | 11.63% | 41.82% |
Free Cash Flow Per Share | -2.19 | -1.47 | -0.96 | -5.23 | 4.50 | 24.40 |
Cash Income Tax Paid | 16.55 | 16.55 | 8.39 | 20.06 | 371.82 | 312.86 |
Levered Free Cash Flow | -170.83 | -158.88 | 36.2 | -561.63 | 129.6 | 1,644 |
Unlevered Free Cash Flow | -170.83 | -158.88 | 36.48 | -561 | 131.05 | 1,645 |
Change in Working Capital | 51.83 | 51.83 | -42.87 | -144.05 | -279.43 | 267.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.